GOID |
Evidence |
Ontology |
Description(GO Term) |
GO:0006641 |
IMPInferred from Mutant Phenotype |
BPBiological Process |
triglyceride metabolic process |
GO:0006642 |
IEAInferred from Electronic Annotation |
BPBiological Process |
triglyceride mobilization |
GO:0006869 |
IEAInferred from Electronic Annotation |
BPBiological Process |
lipid transport |
GO:0007186 |
IDAInferred from Direct Assay |
BPBiological Process |
G-protein coupled receptor protein signaling pathway |
GO:0008203 |
IEAInferred from Electronic Annotation |
BPBiological Process |
cholesterol metabolic process |
GO:0010897 |
IDAInferred from Direct Assay |
BPBiological Process |
negative regulation of triglyceride catabolic process |
GO:0010903 |
IDAInferred from Direct Assay |
BPBiological Process |
negative regulation of very-low-density lipoprotein particle remodeling |
GO:0010916 |
IDAInferred from Direct Assay |
BPBiological Process |
negative regulation of very-low-density lipoprotein particle clearance |
GO:0010987 |
IMPInferred from Mutant Phenotype |
BPBiological Process |
negative regulation of high-density lipoprotein particle clearance |
GO:0010989 |
IMPInferred from Mutant Phenotype |
BPBiological Process |
negative regulation of low-density lipoprotein particle clearance |
GO:0019433 |
IDAInferred from Direct Assay |
BPBiological Process |
triglyceride catabolic process |
GO:0032488 |
IDAInferred from Direct Assay |
BPBiological Process |
Cdc42 protein signal transduction |
GO:0033344 |
IDAInferred from Direct Assay |
BPBiological Process |
cholesterol efflux |
GO:0033700 |
IDAInferred from Direct Assay |
BPBiological Process |
phospholipid efflux |
GO:0034375 |
IMPInferred from Mutant Phenotype |
BPBiological Process |
high-density lipoprotein particle remodeling |
GO:0034379 |
TASTraceable Author Statement |
BPBiological Process |
very-low-density lipoprotein particle assembly |
GO:0034382 |
IDAInferred from Direct Assay |
BPBiological Process |
chylomicron remnant clearance |
GO:0042157 |
IEAInferred from Electronic Annotation |
BPBiological Process |
lipoprotein metabolic process |
GO:0042632 |
IMPInferred from Mutant Phenotype |
BPBiological Process |
cholesterol homeostasis |
GO:0045717 |
IDAInferred from Direct Assay |
BPBiological Process |
negative regulation of fatty acid biosynthetic process |
GO:0045833 |
IDAInferred from Direct Assay |
BPBiological Process |
negative regulation of lipid metabolic process |
GO:0048261 |
IDAInferred from Direct Assay |
BPBiological Process |
negative regulation of receptor-mediated endocytosis |
GO:0050995 |
IDAInferred from Direct Assay |
BPBiological Process |
negative regulation of lipid catabolic process |
GO:0051005 |
IDAInferred from Direct Assay |
BPBiological Process |
negative regulation of lipoprotein lipase activity |
GO:0060621 |
IMPInferred from Mutant Phenotype |
BPBiological Process |
negative regulation of cholesterol import |
GO:0070328 |
IMPInferred from Mutant Phenotype |
BPBiological Process |
triglyceride homeostasis |
GO:0005576 |
EXPInferred from Experiment |
CCCellular Component |
extracellular region |
GO:0005615 |
IDAInferred from Direct Assay |
CCCellular Component |
extracellular space |
GO:0034361 |
IDAInferred from Direct Assay |
CCCellular Component |
very-low-density lipoprotein particle |
GO:0034363 |
IDAInferred from Direct Assay |
CCCellular Component |
intermediate-density lipoprotein particle |
GO:0034366 |
IDAInferred from Direct Assay |
CCCellular Component |
spherical high-density lipoprotein particle |
GO:0042627 |
IDAInferred from Direct Assay |
CCCellular Component |
chylomicron |
GO:0005543 |
IDAInferred from Direct Assay |
MFMolecular Function |
phospholipid binding |
GO:0030234 |
IDAInferred from Direct Assay |
MFMolecular Function |
enzyme regulator activity |
GO:0055102 |
IDAInferred from Direct Assay |
MFMolecular Function |
lipase inhibitor activity |
GO:0070653 |
IPIInferred from Physical Interaction |
MFMolecular Function |
high-density lipoprotein receptor binding |
[